Acasti Pharma (TSXV:ACST) Marketable Securities : C$0.00 Mil (As of Dec. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Acasti Pharma Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Acasti Pharma's Marketable Securities for the quarter that ended in Dec. 2024 was C$0.00 Mil.

Acasti Pharma's annual Marketable Securities declined from Mar. 2022 (C$16.87 Mil) to Mar. 2023 (C$0.02 Mil) and declined from Mar. 2023 (C$0.02 Mil) to Mar. 2024 (C$0.00 Mil).

Acasti Pharma Marketable Securities Historical Data

The historical data trend for Acasti Pharma's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acasti Pharma Marketable Securities Chart

Acasti Pharma Annual Data

Trend

Feb14

Feb15

Feb16

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Marketable Securities

Get a 7-Day Free Trial

12.30

16.87

0.02

Acasti Pharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Marketable Securities	Get a 7-Day Free Trial															8.81	-	0.02	0.02	-

Acasti Pharma Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Acasti Pharma (TSXV:ACST) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Acasti Pharma Marketable Securities Related Terms

Thank you for viewing the detailed overview of Acasti Pharma's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Acasti Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acasti Pharma Inc (TSXV:ACST) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

GRCE:USA

Address

103 Carnegie Center, Suite 300, Princeton, NJ, USA, 08540

Website

https://www.acastipharma.com

Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.

Executives

Donald John Olds	Director
Jean-françois Boily	Senior Officer
Jean-marie Canan	Director

Acasti Pharma Headlines

No Headlines